160 related articles for article (PubMed ID: 32647375)
21. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
[TBL] [Abstract][Full Text] [Related]
22. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer.
Wang Y; Li N; Jiang W; Deng W; Ye R; Xu C; Qiao Y; Sharma A; Zhang M; Hung MC; Lin SH
Clin Cancer Res; 2018 Nov; 24(22):5744-5756. PubMed ID: 30068711
[No Abstract] [Full Text] [Related]
23. Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
Zhang C; Xiao X; Chen M; Aldharee H; Chen Y; Long W
Oncol Rep; 2018 Jan; 39(1):376-382. PubMed ID: 29138862
[TBL] [Abstract][Full Text] [Related]
24. Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.
Kim N; Yim HY; He N; Lee CJ; Kim JH; Choi JS; Lee HS; Kim S; Jeong E; Song M; Jeon SM; Kim WY; Mills GB; Cho YY; Yoon S
Sci Rep; 2016 Jul; 6():29721. PubMed ID: 27431571
[TBL] [Abstract][Full Text] [Related]
25. LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions.
Liu F; Jin R; Liu X; Huang H; Wilkinson SC; Zhong D; Khuri FR; Fu H; Marcus A; He Y; Zhou W
Oncotarget; 2016 Jan; 7(3):2519-31. PubMed ID: 26506235
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
27. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
Tiainen M; Ylikorkala A; Mäkelä TP
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
[TBL] [Abstract][Full Text] [Related]
28. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
[TBL] [Abstract][Full Text] [Related]
29. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Kim J; Hu Z; Cai L; Li K; Choi E; Faubert B; Bezwada D; Rodriguez-Canales J; Villalobos P; Lin YF; Ni M; Huffman KE; Girard L; Byers LA; Unsal-Kacmaz K; Peña CG; Heymach JV; Wauters E; Vansteenkiste J; Castrillon DH; Chen BPC; Wistuba I; Lambrechts D; Xu J; Minna JD; DeBerardinis RJ
Nature; 2017 Jun; 546(7656):168-172. PubMed ID: 28538732
[TBL] [Abstract][Full Text] [Related]
30. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
[TBL] [Abstract][Full Text] [Related]
32. Overexpression and Selective Anticancer Efficacy of
Park C; Lee Y; Je S; Chang S; Kim N; Jeong E; Yoon S
Mol Cells; 2019 Nov; 42(11):804-809. PubMed ID: 31697874
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
34. Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway.
Jimenez AI; Fernandez P; Dominguez O; Dopazo A; Sanchez-Cespedes M
Cancer Res; 2003 Mar; 63(6):1382-8. PubMed ID: 12649203
[TBL] [Abstract][Full Text] [Related]
35. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
[TBL] [Abstract][Full Text] [Related]
36. Controlling the master-upstream regulation of the tumor suppressor LKB1.
Kullmann L; Krahn MP
Oncogene; 2018 Jun; 37(23):3045-3057. PubMed ID: 29540834
[TBL] [Abstract][Full Text] [Related]
37. An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.
Murray CW; Brady JJ; Tsai MK; Li C; Winters IP; Tang R; Andrejka L; Ma RK; Kunder CA; Chu P; Winslow MM
Cancer Discov; 2019 Nov; 9(11):1590-1605. PubMed ID: 31350327
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.
He N; Kim N; Song M; Park C; Kim S; Park EY; Yim HY; Kim K; Park JH; Kim KI; Zhang F; Mills GB; Yoon S
Mol Cancer Ther; 2014 Oct; 13(10):2463-73. PubMed ID: 25122068
[TBL] [Abstract][Full Text] [Related]
39. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression.
Mao K; Liu F; Liu X; Khuri FR; Marcus AI; Li M; Zhou W
Lung Cancer; 2015 May; 88(2):131-8. PubMed ID: 25769882
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA LINC00520 promotes the proliferation and metastasis of malignant melanoma by inducing the miR-125b-5p/EIF5A2 axis.
Luan W; Ding Y; Yuan H; Ma S; Ruan H; Wang J; Lu F; Bu X
J Exp Clin Cancer Res; 2020 May; 39(1):96. PubMed ID: 32466797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
